🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Palatin Technologies Inc (0KF3)

London
Currency in USD
Disclaimer
1.47
-2.63(-64.15%)
Closed
0KF3 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.471.47
52 wk Range
1.355.12
Prev. Close
4.1
Open
1.47
Day's Range
1.47-1.47
52 wk Range
1.35-5.12
Volume
80
Average Volume (3m)
957
1-Year Change
-34.08%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
0KF3 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
11.50
Upside
+677.03%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Palatin Technologies Inc Company Profile

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Compare 0KF3 to Peers and Sector

Metrics to compare
0KF3
Peers
Sector
Relationship
P/E Ratio
−0.8x7.0x−0.6x
PEG Ratio
−1.220.020.00
Price/Book
17.5x2.0x2.6x
Price / LTM Sales
4.7x3.6x3.1x
Upside (Analyst Target)
-142.7%56.1%
Fair Value Upside
Unlock25.9%7.8%Unlock

People Also Watch

0.9600
MCRB
-8.57%
3.6000
TOVX
-7.46%
4.9900
CRIS
-2.16%
0.6602
BNOX
+0.41%
5.2200
COMM
+1.56%

FAQ

What Is the Palatin (0KF3) Stock Price Today?

The Palatin stock price today is 1.47

What Stock Exchange Does Palatin Trade On?

Palatin is listed and trades on the London stock exchange.

What Is the Stock Symbol for Palatin?

The stock symbol for Palatin is "0KF3."

What Is the Palatin Market Cap?

As of today, Palatin market cap is 28.09M.

What is Palatin Earnings Per Share?

The Palatin EPS is -2.59.

What Is the Next Palatin Earnings Date?

Palatin will release its next earnings report on 11 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.